» Articles » PMID: 24525081

Prediction of Acute Pancreatitis Risk Based on PIP Score in Children with Cystic Fibrosis

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2014 Feb 15
PMID 24525081
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Currently no tools to predict risk of acute (AP) and recurrent pancreatitis (ARP) in children with cystic fibrosis (CF) are available. We assessed the prevalence of AP/ARP and tested the potential role of Pancreatic Insufficiency Prevalence (PIP) score in a cohort of children with CF.

Methods: We identified two groups of children, on the basis of presence/absence of AP/ARP, who were compared for age at diagnosis, clinical features, genotypes and sweat chloride level. PIP score was calculated for each patient.

Results: 10/167 (5.9%) experienced at least one episode of AP during follow up; 10/10 were pancreatic sufficient (PS). Patients with AP/ARP showed a PIP score ≤0.25 more frequently (6/10) than patients without AP/ARP. The odds ratio (95% CI) of developing pancreatitis was 4.54 (1.22-16.92) for patients with PIP <0.25 when compared with those who have a PIP score >0.25 (p 0.0151). PIP score was correlated with sweat chloride test (p < 0.01).

Conclusion: PIP score, PS status and normal/borderline sweat chloride levels could be applied to predict pancreatitis development in children with CF. ARP could lead to pancreatic insufficiency.

Citing Articles

-Related Metabolic Syndrome: Genetic Variants Increasing Pancreatitis Risk in the Pediatric Puerto Rican Population.

Melendez-Montanez J, De Jesus-Rojas W Children (Basel). 2023; 10(2).

PMID: 36832409 PMC: 9955436. DOI: 10.3390/children10020280.


Modulator Therapy in Cystic Fibrosis Patients with Variants in F508del Complex Allele: A Short-Term Observational Case Series.

Terlizzi V, Centrone C, Ferrari B, Castellani C, Gunawardena T, Taccetti G J Pers Med. 2022; 12(9).

PMID: 36143206 PMC: 9504164. DOI: 10.3390/jpm12091421.


Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index.

Terlizzi V, Castellani C, Taccetti G, Ferrari B Ital J Pediatr. 2022; 48(1):141.

PMID: 35927765 PMC: 9351191. DOI: 10.1186/s13052-022-01331-5.


Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis.

Zyryanov S, Ushkalova E, Kondratyeva E, Butranova O, Kondakova Y Biomedicines. 2022; 10(5).

PMID: 35625789 PMC: 9139162. DOI: 10.3390/biomedicines10051050.


Pancreatic Insufficiency in a Child with p.Gly542* and c.2657+5G>A Heterozygote CFTR: A Case Report.

Dos Anjos F, Wruck J, do Carmo T, Soares V, de Resende E Silva D, Bagatini M Clin Med Res. 2022; 20(1):46-51.

PMID: 35131845 PMC: 9390849. DOI: 10.3121/cmr.2022.1618.